Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Beyond Medical Technologies Inc C.DOCT

Alternate Symbol(s):  DOCKF

Beyond Medical Technologies Inc. is a Canada-based company. The Company has no business operations and has no revenue. The Company is seeking new business opportunities.

CSE:DOCT - Post Discussion

View:
Post by EDMINNEMA on Oct 09, 2021 9:38am

KAL AND COMPANY

Are a bunch of buffons. I dont think whaat they do is totally legal either. Go to their website, i didnt even see DOCT listed as one of their many companies. I am starting to wonder if they do the same with all thier other so called companies, siphon them dry. They are obviously in hiding, azzclowns, they respond to nothing. They should be totally banned from stock market activties.
Comment by EDMINNEMA on Oct 23, 2021 10:31am
i think shareholders in all the companies who are associated with theses clowns should file official complaints with the various regulatory officials
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities